1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. KINNATE BIOPHARMA INC
Kinnate Biopharma Inc XNAS: KNTE

Watchlist

Portfolio

Alert


Insider Trading disclosures for Kinnate Biopharma Inc

The latest disclosure was made by Mark A. Meltz in Kinnate Biopharma Inc where a trade of 558 Common Stock done at an average price of $2.6 was reported to US exchanges on March 1, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Mark A. Meltz COO GENERAL COUNSEL SECRETARY Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.59 per share. 01 Mar 2024 558 27,578 - 2.6 1,445 Common Stock
Richard Thomas Williams CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.59 per share. 01 Mar 2024 558 67,588 - 2.6 1,445 Common Stock
Neha Krishnamohan CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.59 per share. 01 Mar 2024 1,506 64,087 - 2.6 3,901 Common Stock
Krishnamohan Neha Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.25 per share. 01 Dec 2023 1,459 65,593 - 2.3 3,283 Common Stock
Meltz A. Mark COO General Counsel Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.25 per share. 01 Dec 2023 541 28,136 - 2.2 1,217 Common Stock
Thomas Williams Richard Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.25 per share. 01 Dec 2023 541 68,146 - 2.2 1,217 Common Stock
Dean Jonathan Mitchell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Carl L. Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Keith Flaherty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Laurie Smaldone Alsup Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Helen Sabzevari Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Melissa B. Epperly Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Mark A. Meltz COO General Counsel Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.30 per share. 01 Jun 2023 541 29,218 - 4.3 2,326 Common Stock
Richard Thomas Williams Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.30 per share. 01 Jun 2023 541 69,228 - 4.3 2,326 Common Stock
Neha Krishnamohan Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.30 per share. 01 Jun 2023 1,459 68,511 - 4.3 6,274 Common Stock
Jim Tananbaum Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.80 per share. 08 May 2023 1,550,956 3,525,957 - 2.8 4,342,677 Common Stock
Jim Tananbaum Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.80 per share. 08 May 2023 229,044 520,711 - 2.8 641,323 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.82 per share. 04 May 2023 490,511 1,368,338 - 2.8 1,383,241 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.75 per share. 04 May 2023 83,459 877,827 - 2.7 229,512 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.75 per share. 04 May 2023 312,991 4,738,453 - 2.7 860,725 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.82 per share. 04 May 2023 490,512 1,368,339 - 2.8 1,383,244 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.75 per share. 04 May 2023 83,459 877,827 - 2.7 229,512 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.67 per share. 28 Apr 2023 220,610 4,425,462 - 2.7 589,029 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.55 per share. 28 Apr 2023 60,998 610,998 - 2.6 155,545 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.55 per share. 28 Apr 2023 228,754 3,737,784 - 2.6 583,323 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.55 per share. 28 Apr 2023 60,997 610,997 - 2.5 155,542 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.62 per share. 28 Apr 2023 124,544 735,542 - 2.6 326,305 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.62 per share. 28 Apr 2023 467,068 4,204,852 - 2.6 1,223,718 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.62 per share. 28 Apr 2023 124,545 735,542 - 2.6 326,308 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.67 per share. 28 Apr 2023 58,826 794,368 - 2.7 157,065 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.67 per share. 28 Apr 2023 58,826 794,368 - 2.7 157,065 Common Stock
Mark A. Meltz COO General Counsel Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.21 per share. 01 Mar 2023 638 27,286 - 5.2 3,324 Common Stock
Richard Thomas Williams Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.21 per share. 01 Mar 2023 638 67,295 - 5.2 3,324 Common Stock
Neha Krishnamohan Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.21 per share. 01 Mar 2023 1,721 67,378 - 5.2 8,966 Common Stock
Jill DeSimone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 50,000 50,000 - - Stock Option (right to buy)
Carl L. Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 550,000 550,000 - - Common Stock
Carl L. Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 550,000 550,000 - - Common Stock
Jim Tananbaum Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 17 Feb 2023 1,100,000 1,975,001 - - Common Stock
Mark A. Meltz COO General Counsel Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2023 215,000 215,000 - - Employee Stock Option (right to buy)
Nima Farzan Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2023 750,000 750,000 - - Employee Stock Option (right to buy)
Richard Thomas Williams Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2023 215,000 215,000 - - Employee Stock Option (right to buy)
Neha Krishnamohan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2023 215,000 215,000 - - Employee Stock Option (right to buy)
Mark A. Meltz COO General Counsel Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.75 per share. 01 Dec 2022 541 27,924 - 7.8 4,193 Common Stock
Richard Thomas Williams Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.75 per share. 01 Dec 2022 541 67,933 - 7.8 4,193 Common Stock
Neha Krishnamohan Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.75 per share. 01 Dec 2022 1,459 69,099 - 7.7 11,307 Common Stock
Mark A. Meltz COO General Counsel Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2022 25,000 28,465 - 0 Common Stock
Richard Thomas Williams Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2022 25,000 68,474 - 0 Common Stock
Neha Krishnamohan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2022 67,500 69,015 - 0 Common Stock
Dean Jonathan Mitchell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 20,250 20,250 - - Stock Option (right to buy)
Carl L. Gordon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 20,250 20,250 - - Stock Option (right to buy)
Keith Flaherty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 20,250 20,250 - - Stock Option (right to buy)
Laurie Smaldone Alsup Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 20,250 20,250 - - Stock Option (right to buy)
Helen Sabzevari Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 20,250 20,250 - - Stock Option (right to buy)
Melissa B. Epperly Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 20,250 20,250 - - Stock Option (right to buy)
Jim Tananbaum Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 20,250 20,250 - - Stock Option (right to buy)
Michael Rome Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 20,250 20,250 - - Stock Option (right to buy)
Richard Thomas Williams Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 8.64 per share. 11 Mar 2022 15,000 17,333 - 8.6 129,600 Common Stock
Richard Thomas Williams Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 8.37 per share. 11 Mar 2022 25,000 42,333 - 8.4 209,250 Common Stock
Carl L. Gordon Director Purchase of securities on an exchange or from another person at price $ 9.96 per share. 11 Feb 2022 9,000 3,509,030 - 10.0 89,640 Common Stock
Carl L. Gordon Director Purchase of securities on an exchange or from another person at price $ 9.89 per share. 11 Feb 2022 10,000 3,500,030 - 9.9 98,900 Common Stock
Carl L. Gordon Director Purchase of securities on an exchange or from another person at price $ 9.98 per share. 11 Feb 2022 20,700 3,490,030 - 10.0 206,586 Common Stock
Carl L. Gordon Director Purchase of securities on an exchange or from another person at price $ 10.22 per share. 11 Feb 2022 156,000 3,469,330 - 10.2 1,594,320 Common Stock
Mark A. Meltz COO General Counsel Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 135,000 135,000 - - Employee Stock Option (right to buy)
Nima Farzan Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 400,000 400,000 - - Employee Stock Option (right to buy)
Richard Thomas Williams Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 135,000 135,000 - - Employee Stock Option (right to buy)
Neha Krishnamohan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 185,000 185,000 - - Employee Stock Option (right to buy)
Dean Jonathan Mitchell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2021 20,250 20,250 - - Stock Option (right to buy)
Keith Flaherty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2021 20,250 20,250 - - Stock Option (right to buy)
Laurie Smaldone Alsup Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2021 20,250 20,250 - - Stock Option (right to buy)
Melissa B. Epperly Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2021 20,250 20,250 - - Stock Option (right to buy)
Neha Krishnamohan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2021 270,000 270,000 - - Employee Stock Option (right to buy)
Mark A. Meltz COO General Counsel Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2021 100,000 100,000 - - Employee Stock Option (right to buy)
Nima Farzan Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2021 275,000 275,000 - - Employee stock option (right to buy)
Eric Anthony Murphy Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2021 60,000 60,000 - - Employee Stock Option (right to buy)
Richard Thomas Williams Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2021 100,000 100,000 - - Employee Stock Option (right to buy)
Carl L Gordon Director, Ten Percent Owner 07 Dec 2020 50,501 50,501 - - Common Stock
Carl L Gordon Director, Ten Percent Owner 07 Dec 2020 243,494 543,494 - - Common Stock
Carl L Gordon Director, Ten Percent Owner 07 Dec 2020 118,398 0 - - Series C Preferred Stock
Carl L Gordon Director, Ten Percent Owner 07 Dec 2020 2,651,042 3,194,536 - - Common Stock
Carl L Gordon Director, Ten Percent Owner 07 Dec 2020 2,651,042 0 - - Series B Preferred Stock
Carl L Gordon Director, Ten Percent Owner 07 Dec 2020 118,794 3,313,330 - - Common Stock
Carl L Gordon Director, Ten Percent Owner 07 Dec 2020 243,494 0 - - Series A Preferred Stock
Carl L Gordon Director, Ten Percent Owner 07 Dec 2020 24,637 84,599 - - Common Stock
Carl L Gordon Director, Ten Percent Owner 07 Dec 2020 24,555 0 - - Series C Preferred Stock
Carl L Gordon Director, Ten Percent Owner 07 Dec 2020 9,461 0 - - Series B Preferred Stock
Carl L Gordon Director, Ten Percent Owner 07 Dec 2020 50,501 0 - - Series A Preferred Stock
Carl L Gordon Director, Ten Percent Owner 07 Dec 2020 9,461 59,962 - - Common Stock
Jim Tananbaum Director, Ten Percent Owner 07 Dec 2020 9,171,643 9,671,643 - 0 Common Stock
Jim Tananbaum Director, Ten Percent Owner 07 Dec 2020 298,465 0 - - Series A Preferred Stock
Jim Tananbaum Director, Ten Percent Owner 07 Dec 2020 6,347,893 0 - - Series A Preferred Stock
Jim Tananbaum Director, Ten Percent Owner 07 Dec 2020 166,667 291,667 - 0 Common Stock
Jim Tananbaum Director, Ten Percent Owner 07 Dec 2020 500,001 875,001 - 0 Common Stock
Jim Tananbaum Director, Ten Percent Owner 07 Dec 2020 48,376 0 - - Series C Preferred Stock
Jim Tananbaum Director, Ten Percent Owner 07 Dec 2020 145,128 0 - - Series C Preferred Stock
Jim Tananbaum Director, Ten Percent Owner 07 Dec 2020 157,222 0 - - Series C Preferred Stock
Jim Tananbaum Director, Ten Percent Owner 07 Dec 2020 18,641 0 - - Series B Preferred Stock
Jim Tananbaum Director, Ten Percent Owner 07 Dec 2020 55,922 0 - - Series B Preferred Stock
Jim Tananbaum Director, Ten Percent Owner 07 Dec 2020 2,666,002 0 - - Series B Preferred Stock
Jim Tananbaum Director, Ten Percent Owner 07 Dec 2020 99,488 0 - - Series A Preferred Stock
Jim Tananbaum Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 20.00 per share. 03 Dec 2020 500,000 500,000 - 20 10,000,000 Common Stock
Jim Tananbaum Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 20.00 per share. 03 Dec 2020 375,000 375,000 - 20 7,500,000 Common Stock
Jim Tananbaum Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 20.00 per share. 03 Dec 2020 125,000 125,000 - 20 2,500,000 Common Stock
Carl L Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 20.00 per share. 02 Dec 2020 300,000 300,000 - 20 6,000,000 Common Stock
Carl L Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2020 40,501 40,501 - - Stock Option (right to buy)
Carl L Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 20.00 per share. 02 Dec 2020 450,000 450,000 - 20 9,000,000 Common Stock
Jim Tananbaum Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2020 40,501 40,501 - - Stock Option (right to buy)
Michael Rome Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2020 40,501 40,501 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters